NCT07332156 2026-01-14
Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas
Samsung Medical Center
Completed
Clinical Trials
1 trialsOTHER × Pulmonary Disease, Chronic Obstructive × Sodium-Glucose Transporter 2 Inhibitors × Clear all